Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC

NCT07244016 · clinicaltrials.gov ↗

RECRUITING

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Sponsor

Henan Cancer Hospital